{"slideshow_credits": null, "snippet": "The agreement partly offsets a similar pact between the pharmacy benefit manager Express Scripts and AbbVie, another maker of a costly hepatitis C drug.", "abstract": "CVS Health announces Gilead Sciences' hepatitis drugs Harvoni and Sovaldi will be exclusive option for its patients; move partly blunts drug plan between Express Scripts and AbbVie.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/01/06/business/gilead-strikes-hepatitis-drug-deal-with-cvs-health.html", "lead_paragraph": "The agreement partly offsets a similar pact between the pharmacy benefit manager Express Scripts and AbbVie, another maker of a costly hepatitis C drug.", "headline": {"main": "Gilead Strikes Hepatitis Drug Deal With CVS Health", "print_headline": "CVS Gives Gilead Exclusivity for Two Hepatitis Drugs"}, "_id": "54ab437838f0d83eda14cc77", "word_count": "435", "multimedia": [], "pub_date": "2015-01-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "CVS Caremark Corporation", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Gilead Sciences Inc", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Hepatitis", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "AbbVie Inc", "name": "organizations", "is_major": "Y", "rank": "5"}, {"value": "Express Scripts Inc", "name": "organizations", "is_major": "Y", "rank": "6"}, {"value": "Harvoni (Drug)", "name": "subject", "is_major": "N", "rank": "7"}, {"value": "Sovaldi (Drug)", "name": "subject", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}